IGF1 and metabolic dysfunction-associated steatotic liver disease: Regarding treatment, favorable effects of recombinant GH (rhGH) on hepatic steatosis and, possibly, on hepatic fibrosis progression in patients with MASLD and GHD or with low IGF-1 concentrations have been demonstrated in interventional studies.